Covance

Activities: Research & Development

Trending Articles

  1. Lonza Capsules & Health Ingredients expands capsule manufacturing capacity in India and China New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari (IN) and Suzhou (CN), highlighting the long-term strategic commitment to...
  2. Causes and solutions for dark spots in tablet manufacturing Natoli Engineering examines the causes and solutions for dark spots that can halt production
  3. Get ahead in the pharmaceutical industry with a Manufacturing Chemist subscription With a Manufacturing Chemist subscription you receive exclusive access to the latest news, technical insights, regulatory updates, and market intelligence
  4. Resolving capping issues in tablet manufacturing Natoli explores the various causes of capping and the methods to prevent it
  5. HOOKIPA Pharma begins non-binding discussions to acquire Poolbeg Pharma The two pharmaceutical companies may create a clinical-stage biopharmaceutical company focused on the development and commercialisation of next-generation immunotherapies

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

Related Content

Media

Pharma outsourcing mergers and acquisitions set for record year in 2015

Value of pharmaceutical outsourcing merger and acquisition deals has more than doubled from US$5.5bn in 2014 to $12bn by October 2015
You need to be a subscriber to read this article.
Click here to find out more.
Research & Development

Focus turns to pre-empting disease causes and ageing

Drug discovery is brimming with innovation and technology but success is still seldom and slow. Susan Birks reports on the changing discovery landscape and how the odds can be improved
Manufacturing

Covance expands global biologics capabilities

New investments in facilities and scientific leadership reflect commitment to biologics development
Analysis

Covance and PathoQuest collaborate on NGS-based biosafety assessments

Innovative biosafety testing approach provides a flexible testing solution to all biotherapeutic clients
Regulatory

Covance and Indiana Clinical and Translational Sciences Institute to conduct early clinical trials

Two organisations will conduct high-quality research in a safe and regulated environment for sponsors who are looking to recruit both healthy volunteers and patients
Regulatory

Steve Street joins Covance

Will oversee worldwide safety assessment and pharmaceutical chemistry services
Finance

Covance and sanofi-aventis finalise r&d alliance

Covance also acquires sanofi-aventis plants in France and the UK
Subscribe now